or Try an Advanced Search...

    Technical Analysis for CRDL - Cardiol Therapeutics Inc

    Grade Last Price % Change Price Change
    F 2.520 -0.79% -0.020
    CRDL closed down 0.79 percent on Monday, November 18, 2024, on 1.15 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CRDL trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    200 DMA Resistance Bearish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Outside Day Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    MACD Bearish Centerline Cross Bearish -0.79%
    Older End-of-Day Signals for CRDL ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR about 12 hours ago
    Fell Below Previous Day's Low about 12 hours ago
    Outside Day about 12 hours ago
    Down 5% about 12 hours ago
    Up 1 ATR about 13 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CRDL Chart by TradingView
    Basic chart:

    Profile

    Cardiol Therapeutics Inc Description

    Cardiol Therapeutics Inc is a Canada-based company engaged in the pharmaceutical business sector. The Company is focused on the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for heart failure and cancer. It has research programs focused on development of nanotherapeutics to treat heart failure underway. The Company invests in development of formulations for three medical markets: commercializing a line of purity pharmaceutically-manufactured cannabidiol products in the market for medical cannabinoids; development of nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure, a cause of death and hospitalization, and pursuing an immunotherapeutics program commencing with a cancer immunotherapeutic in combination with cannabinoids for treating Glioblastoma Multiforme.

    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharma Pharmaceutical Drug Cancer Drugs Heart Organ Systems Cannabinoid Blastoma Cannabidiol Cannabinoids Glioblastoma Pharmaceutical Business Sector

    Is CRDL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 10 Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024
    Jul 12 We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate
    Jun 27 Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders
    Jun 25 Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT
    Jun 17 Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
    Jun 13 Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
    See more CRDL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.26
    52 Week Low 1.07
    Average Volume 126,957
    200-Day Moving Average 2.664
    50-Day Moving Average 2.742
    20-Day Moving Average 2.635
    10-Day Moving Average 2.683
    Average True Range 0.161
    RSI (14) 41.86
    ADX 16.55
    +DI 18.233
    -DI 21.663
    Chandelier Exit (Long, 3 ATRs) 2.456
    Chandelier Exit (Short, 3 ATRs) 2.864
    Upper Bollinger Bands 2.828
    Lower Bollinger Band 2.441
    Percent B (%b) 0.2
    BandWidth 14.696
    MACD Line -0.021
    MACD Signal Line -0.011
    MACD Histogram -0.0101
    Fundamentals Value
    Market Cap 82.69 Million
    Num Shares 32.8 Million
    EPS -1.02
    Price-to-Earnings (P/E) Ratio -2.47
    Price-to-Sales 0.00
    Price-to-Book 3.94
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.985
    Resistance 3 (R3) 2.990 2.840 2.908
    Resistance 2 (R2) 2.840 2.722 2.838 2.882
    Resistance 1 (R1) 2.680 2.648 2.605 2.675 2.856
    Pivot Point 2.530 2.530 2.493 2.528 2.530
    Support 1 (S1) 2.370 2.412 2.295 2.365 2.184
    Support 2 (S2) 2.220 2.338 2.218 2.158
    Support 3 (S3) 2.060 2.220 2.133
    Support 4 (S4) 2.055